A new study led by the Congenital Heart Initiative explores quality of life, mental health, and physical activity outcomes in a large cohort of adults with congenital heart disease.
The FDA approved the first treatment for patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and life-threatening blood clotting disorder that may be fatal if left...
A team of researchers sought to find the effectiveness of high spinal anesthesia and general anesthesia in postoperative recovery times among pediatric patients undergoing congenital heart surgery.
Ivacaftor appears to be safe for young children with cystic fibrosis, though elevated liver function tests may call for increased monitoring, according to research from the KIWI study group.
